<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Anesth Essays Res</journal-id><journal-id journal-id-type="iso-abbrev">Anesth Essays Res</journal-id><journal-id journal-id-type="publisher-id">AER</journal-id><journal-title-group><journal-title>Anesthesia, Essays and Researches</journal-title></journal-title-group><issn pub-type="ppub">0259-1162</issn><issn pub-type="epub">2229-7685</issn><publisher><publisher-name>Medknow Publications &#x00026; Media Pvt Ltd</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28928570</article-id><article-id pub-id-type="pmc">5594789</article-id><article-id pub-id-type="publisher-id">AER-11-676</article-id><article-id pub-id-type="doi">10.4103/0259-1162.204208</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Gabapentinoids as a Part of Multi-modal Drug Regime for Pain Relief following Laproscopic Cholecystectomy: A Randomized Study</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Kochhar</surname><given-names>Anjali</given-names></name><xref ref-type="aff" rid="aff1"/><xref ref-type="corresp" rid="cor1"/></contrib><contrib contrib-type="author"><name><surname>Chouhan</surname><given-names>Kanika</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Panjiar</surname><given-names>Pratibha</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Vajifdar</surname><given-names>Homay</given-names></name><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff id="aff1">Department of Anesthesia, Hamdard Institute of Medical Sciences and Research, Jamia Hamdard, New Delhi, India</aff><author-notes><corresp id="cor1"><bold>Address for correspondence:</bold> Dr. Anjali Kochhar, Department of Anesthesia, Hamdard Institute of Medical Sciences and Research, Jamia Hamdard, New Delhi, India. E-mail: <email xlink:href="kochharanjali0@gmail.com">kochharanjali0@gmail.com</email></corresp></author-notes><pub-date pub-type="ppub"><season>Jul-Sep</season><year>2017</year></pub-date><volume>11</volume><issue>3</issue><fpage>676</fpage><lpage>680</lpage><permissions><copyright-statement>Copyright: &#x000a9; 2017 Anesthesia: Essays and Researches</copyright-statement><copyright-year>2017</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.</license-p></license></permissions><abstract><sec id="st1"><title>Background:</title><p>Gabapentinoids have been used as preemptive analgesics for pain management following laparoscopic cholecystectomy. Recently, multimodal analgesic techniques have been found superior to preemptive analgesia alone.</p></sec><sec id="st2"><title>Aim:</title><p>The aim of this study is to evaluate and compare a single preoperative dose of pregabalin 150 mg and gabapentin 300 mg for pain relief following laparoscopic cholecystectomy as a part of multimodal drug regime.</p></sec><sec id="st3"><title>Settings and Design:</title><p>This randomized, single-blind study was conducted after Ethical Committee approval and written informed consent from the patients.</p></sec><sec id="st4"><title>Materials and Methods:</title><p>Fifty patients undergoing laparoscopic cholecystectomy under general anesthesia were randomly allocated to receive either 150 mg pregabalin (Group PG), or 300 mg gabapentin (Group GB) orally, 2 h before surgery. Standard anesthesia induction and maintenance were done. For intraoperative pain management, injection fentanyl 2 &#x003bc;g.kg<sup>-1</sup> intravenous (IV) along with injection voveran 75 mg IV and port site infiltration was used. Postoperatively, injection diclofenac 75 mg intramuscular TDS was continued. Severity of postoperative pain (visual analog scale [VAS]), postoperative fentanyl requirement and incidence, and severity of side effects were assessed. When VAS &#x0003e;40 mm or on patient's request, a Fentanyl bolus at an increment of 25&#x02013;50 &#x003bc;g IV was given as rescue analgesia.</p></sec><sec id="st5"><title>Results:</title><p>Intraoperative fentanyl requirement was 135 &#x000b1; 14 &#x003bc;g in Group PG and 140 &#x000b1; 14 &#x003bc;g in Group GB (<italic>P</italic> = 0.21). Postoperative, fentanyl requirement was 123 &#x000b1; 18 &#x003bc;g in Group PG and 131 &#x000b1; 23 &#x003bc;g in Group GB (<italic>P</italic> = 0.17) There was no statistically significant difference in the VAS score for static and dynamic pain. Time to the first requirement of analgesic was 5.4 &#x000b1; 1.1 h in Group PG and 4.6 &#x000b1; 1.6 h in Group GB (<italic>P</italic> = 0.015). No side effects were observed.</p></sec><sec id="st6"><title>Conclusion:</title><p>We conclude that a single preoperative dose of pregabalin (150 mg) or gabapentin (300 mg) are equally efficacious in providing pain relief following laparoscopic cholecystectomy as a part of multimodal regime without any side effects.</p></sec></abstract><kwd-group><kwd>Gabapentin</kwd><kwd>laparoscopic cholecystectomy</kwd><kwd>multi-modal analgesia</kwd><kwd>pregabalin</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-1"><title>I<sc>NTRODUCTION</sc></title><p>Multimodal analgesic techniques have gained popularity for postoperative pain management. The major advantage being superior pain control with reduced side effects as opioids consumption is decreased. Drugs used include nonsteroidal anti-inflammatory drugs, selective cyclooxygenase-2 inhibitors, N-methyl-D-aspartate antagonists, alpha-2 adrenergic agonists, gabapentinoids, and local anesthetic injection at the surgical site.[<xref rid="ref1" ref-type="bibr">1</xref>]</p><p>Gabapentinoids drugs (gabapentin and pregabalin) were developed originally as anticonvulsants and subsequently found to be effective in neuropathic and postoperative pain management.[<xref rid="ref2" ref-type="bibr">2</xref><xref rid="ref3" ref-type="bibr">3</xref><xref rid="ref4" ref-type="bibr">4</xref><xref rid="ref5" ref-type="bibr">5</xref>]</p><p>Pregabalin compared to gabapentin has better pharmacokinetic profile with rapid absorption, higher bioavailability, and less intersubject variability.[<xref rid="ref6" ref-type="bibr">6</xref>] Animal studies show that pregabalin is 3&#x02013;10-folds more potent than gabapentin as an epileptic and 2&#x02013;4-fold more potent as an analgesic in the treatment of chronic neuropathic pain.[<xref rid="ref7" ref-type="bibr">7</xref><xref rid="ref8" ref-type="bibr">8</xref>]</p><p>Various studies separately evaluating the role of these drugs for pain relief following laparoscopic cholecystectomy show that a single preoperative dose of pregabalin (150 mg) or gabapentin (300 mg) is effective in reducing pain scores and opioid consumption.[<xref rid="ref9" ref-type="bibr">9</xref><xref rid="ref10" ref-type="bibr">10</xref><xref rid="ref11" ref-type="bibr">11</xref>]</p><p>Recently studies have been done comparing the effectiveness of these drugs as preemptive analgesics in prolonging the duration of spinal anesthesia. Both the drugs prolong the duration of postoperative analgesia compared to placebo. Pregabalin (300 mg) was found to be superior to gabapentin (900&#x02013;1200 mg).[<xref rid="ref12" ref-type="bibr">12</xref><xref rid="ref13" ref-type="bibr">13</xref><xref rid="ref14" ref-type="bibr">14</xref>]</p><p>Mishra <italic>et al</italic>. compared pregabalin (150 mg) and gabapentin (900 mg) for pain relief following laparoscopic cholecystectomy. Both the drugs were found to be effective in reducing pain as compared to placebo. Side effects including sedation, nausea vomiting, respiratory depression, and vertigo were observed in all the groups.[<xref rid="ref15" ref-type="bibr">15</xref>]</p><p>Recent research shows that preventive analgesia using multimodal techniques in the perioperative period is more effective than using drugs preincision (preemptive analgesia).[<xref rid="ref16" ref-type="bibr">16</xref>] None of these studies show the effects of these drugs when a multimodal approach to pain management is used.</p><p>Hence, we planned a study to evaluate and compare a single preoperative dose of pregabalin 150 mg and gabapentin 300 mg for pain relief following laparoscopic cholecystectomy as a part of multimodal drug regime.</p></sec><sec sec-type="materials|methods" id="sec1-2"><title>M<sc>ATERIALS AND</sc> M<sc>ETHODS</sc></title><p>This randomized, single-blind study was conducted in the Department of Anaesthesiology, Hamdard Institute of Medical Sciences and Research after taking approval of the Institutional Ethical Committee and written informed consent from the patients.</p><p>Adult patients of either sex, age (18&#x02013;60 years), with physical status American Society of Anesthesiologists (ASA) Classes I and II, undergoing laparoscopic cholecystectomy under general anesthesia were included in the study. Patients having history of chronic pain, drug abuse, pregnancy, and altered kidney or liver function were excluded from the study.</p><p>Patients meeting the inclusion criteria during the preanesthetic evaluation were randomly assigned into two groups of 25 each with the help of a computer-generated table of random numbers, to receive either 150 mg pregabalin (Group PG) or 300 mg gabapentin (Group GB). All the medications were provided by hospital pharmacy and were administered orally, 2 h before the induction of anesthesia with sips of water by a staff nurse who was not involved in the study.</p><p>Anesthesia technique was standardized in both the groups. Patients were induced with fentanyl 2 &#x003bc;g.kg<sup>-1</sup> intravenous (IV) and propofol 2 mg.kg<sup>-1</sup> IV; orotracheal intubation was facilitated by vecuronium 0.08mg.kg<sup>-1</sup> IV. Anesthesia was maintained using isoflurane and 66% nitrous oxide in oxygen. Supplemental fentanyl bolus and vecuronium were given as per anesthesiologist's discretion. All patients were given a single IV dose of prophylactic antiemetic, ondansetron 4 mg. Injection voveran 75 mg IV and port site infiltration with 0.25% bupivacaine were given for postoperative analgesia as a part of multimodal analgesic technique. At the end of surgery, residual neuromuscular paralysis was antagonized with neostigmine 0.05 mg.kg<sup>-1</sup> IV and glycopyrrolate 0.01 mg.kg<sup>-1</sup> IV. After satisfactory recovery, the patients were extubated and shifted to the postanesthesia Care Unit (PACU).</p><p>When visual analog scale (VAS) &#x0003e;40 mm or patient's request, a fentanyl bolus at an increment of 25&#x02013;50 &#x003bc;g IV was titrated with the standard protocol in the PACU. Injection diclofenac 75 mg intramuscular TDS was continued postoperatively.</p><p>Severity of postoperative pain, postoperative fentanyl requirement, incidence, and severity of side effects such as postoperative nausea and vomiting, shivering headache, sedation, vision abnormalities (blurring of vision, double vision), and respiratory depression, if any were recorded.</p><p>The primary outcome was severity of postoperative pain and postoperative analgesic requirement and secondary outcome the incidence and severity of side effects. Both these outcomes were assessed by an independent anesthesiologist blinded to group allocation. Assessment of pain both at rest (static) and during coughing (dynamic) was done by a 100 mm VAS; 0, no pain; 100, worst imaginable pain. Assessment of pain was done on arrival of the patient to the PACU (0) and then every 2 h till the end of the study, that is, 24 h after operation. Sedation was assessed by Ramsay sedation score. Patients having sedation score &#x0003e;2 were considered sedated.</p><sec id="sec2-1"><title>Statistical analysis</title><p>A reduction of VAS score to 30 mm was considered effective. With an &#x003b1; error of 0.05 and power of 80%, a sample size of 25 patients in each group was taken. Maximum pain scores at different time intervals (0, 0&#x02013;4, 4&#x02013;8, 8&#x02013;12, and 12&#x02013;24 h) for each patient were considered for statistical analysis. Student's <italic>t</italic>-test was used for calculating fentanyl consumption.</p></sec></sec><sec sec-type="results" id="sec1-3"><title>R<sc>ESULTS</sc></title><p>A total of fifty patients were enrolled, all the patients were ASA Grade I. There were no dropouts. There was no significant difference in demographic profile and duration of surgery [<xref ref-type="table" rid="T1">Table 1</xref>].</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Demographic data and duration of surgery (mean&#x000b1;standard deviation)</p></caption><graphic xlink:href="AER-11-676-g001"/></table-wrap><p>Intraoperative fentanyl requirement was 135 &#x000b1; 14 &#x003bc;g in Group PG and 140 &#x000b1; 14 &#x003bc;g in Group GB (<italic>P</italic> = 0.21) [<xref ref-type="table" rid="T2">Table 2</xref>].</p><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Fentanyl requirement and time to first analgesic request (mean&#x000b1;standard deviation)</p></caption><graphic xlink:href="AER-11-676-g002"/></table-wrap><p>Patients who received pregabalin 150 mg (Group PG) had comparatively lower VAS scores for static pain at all time intervals compared those who received gabapentin (Group GB). The difference was not statistically significant [<xref ref-type="fig" rid="F1">Figure 1</xref>].</p><fig id="F1" position="float"><label>Figure 1</label><caption><p>Postoperative visual analog scale (static pain). No statistically significant difference in visual analog scale (static pain) at all intervals</p></caption><graphic xlink:href="AER-11-676-g003"/></fig><p>Dynamic pain scores (VAS) were lower in Group PG as compared to Group GB at all intervals. The difference was not statistically significant [<xref ref-type="fig" rid="F2">Figure 2</xref>].</p><fig id="F2" position="float"><label>Figure 2</label><caption><p>Postoperative visual analog scale (dynamic pain). No statistically significant difference in visual analog scale (dynamic pain) at all intervals</p></caption><graphic xlink:href="AER-11-676-g004"/></fig><p>Time to first requirement of analgesic was 5.4 &#x000b1; 1.1 h in Group PG and 4.6 &#x000b1; 1.6 h in Group GB. The difference was found to be statistically significant (<italic>P</italic> = 0.015) [<xref ref-type="fig" rid="F3">Figure 3</xref>].</p><fig id="F3" position="float"><label>Figure 3</label><caption><p>Time to rescue analgesia. The difference was statistically significant (<italic>P</italic> = 0.015)</p></caption><graphic xlink:href="AER-11-676-g005"/></fig><p>Postoperative fentanyl requirement was 123 &#x000b1; 18 &#x003bc;g in Group PG and 131 &#x000b1; 23 &#x003bc;g in Group GB. The difference was found to be statistically nonsignificant (<italic>P</italic> = 0.17) [<xref ref-type="table" rid="T2">Table 2</xref>].</p><p>Twelve percent of patients in Group PG and 8% in Group GB were observed to have sedation levels &#x0003e;2 in the immediate postoperative period. None of the other side effects were observed.</p></sec><sec sec-type="discussion" id="sec1-4"><title>D<sc>ISCUSSION</sc></title><p>Gabapentinoids have been recommended for perioperative administration to improve acute pain after surgery and are being used as a part of multimodal approach to postoperative pain control.[<xref rid="ref1" ref-type="bibr">1</xref>] These drugs reduce the hyperexcitability of dorsal horn neurons induced by tissue damage rather than affecting afferent input from the site of injury.[<xref rid="ref17" ref-type="bibr">17</xref>]</p><p>We used a single preoperative dose of pregabalin 150 mg and gabapentin 300 mg. Dose selection was based on pharmacokinetic, pharmacodynamics, and side effects of both the drugs reported in literature. The relative potency of pregabalin is 2&#x02013;4-fold higher with favorable pharmacokinetic profile.[<xref rid="ref7" ref-type="bibr">7</xref><xref rid="ref8" ref-type="bibr">8</xref>]</p><p>Various studies show that 150 mg of pregabalin administered 1 h before surgery is effective with minimal side effects where as lower dose of pregabalin (50&#x02013;75 mg) does not reduce opioid consumption following laparoscopic cholecystectomy.[<xref rid="ref9" ref-type="bibr">9</xref><xref rid="ref10" ref-type="bibr">10</xref><xref rid="ref18" ref-type="bibr">18</xref>]</p><p>Optimal dose of gabapentin for laparoscopic cholecystectomy has not been identified. Pandey <italic>et al</italic>. evaluated optimal dose of gabapentin for lumbar discectomy. Optimal dose was identified to be 600 mg. Laparoscopic cholecystectomy comparative less painful procedure than lumbar discectomy. In addition, gabapentin 300 mg has been shown to be effective in reducing postoperative pain and opioid consumption following laparoscopic cholecystectomy and lower limb orthopedic surgery.[<xref rid="ref11" ref-type="bibr">11</xref><xref rid="ref19" ref-type="bibr">19</xref><xref rid="ref20" ref-type="bibr">20</xref>]</p><p>Studies show that higher doses of pregabalin (300&#x02013;600 mg) and gabapentin (600&#x02013;1200 mg) can produce side effects such as sedation, dizziness, and blurred vision.[<xref rid="ref21" ref-type="bibr">21</xref><xref rid="ref22" ref-type="bibr">22</xref><xref rid="ref23" ref-type="bibr">23</xref><xref rid="ref24" ref-type="bibr">24</xref>]</p><p>The results of our study show no statistically significant difference in the static and dynamic pain scores in both the groups.</p><p>Our results are in contrast with those reported by Mishra <italic>et al</italic>., who compared pregabalin (150 mg) with gabapentin (900 mg) and placebo, in patients undergoing laparoscopic cholecystectomy. All the drugs were given 1 h preoperatively. Postoperative pain management was done using injection tramadol. The results of their study show lower VAS score in the Groups PG and GB than placebo. Among gabapentinoids, Group PG had lower VAS scores.[<xref rid="ref15" ref-type="bibr">15</xref>]</p><p>Major reasons for these differences might be due to use of drugs 2 h before surgery and multimodal approach of pain management in our study. Pharmacokinetic properties of gabapentin show that its bioavailability varies inversely with dose (single dose of 300 mg and 600 mg has bioavailability of 60% and 40% respectively) and peak effect occurs in 2&#x02013;3 h. Preventive analgesia using multimodal approach helps in reducing postoperative pain and analgesic requirement. The dose of individual drug is reduced. Mechanism of preventive analgesia being decrease in hyperalgesia, peripheral, and central sensitization.[<xref rid="ref16" ref-type="bibr">16</xref>]</p><p>The requirement of supplemental doses of fentanyl in the postoperative period was similar in both the groups. Ghai <italic>et al</italic>. compared the effects of gabapentin (900 mg) and pregabalin (300 mg) in patients undergoing hysterectomy. The consumption of diclofenac was similar in Group PG and GB.[<xref rid="ref25" ref-type="bibr">25</xref>]</p><p>In our study, time to rescue analgesia was found to be longer in Group PG. Similar findings were observed in the study was conducted by Saraswat and Arora comparing the analgesic efficacy of gabapentin (1200 mg) and pregabalin (300 mg) in surgery under spinal anesthesia. The duration of analgesia was 8.9 h in Group GB and 14.17 h in Group PG.[<xref rid="ref26" ref-type="bibr">26</xref>]</p><p>Three of the patients in pregabalin were observed to be sedated compared to two in gabapentin. None of our patients had any other adverse effects.</p><p>Side effects reported by Ghai <italic>et al</italic>. include high incidence of somnolence (40% and 33.3% with pregabalin 300 mg and gabapentin 900 mg respectively). Saraswat and Arora observed sedation and dizziness in both the groups (1200 mg of gabapentin vs. 300 mg of pregabalin).</p><p>Lesser incidence of side effects observed in our study may be due to lower doses of pregabalin and gabapentin used and use of multimodal regime to reduce the requirement of opioids.</p><p>Major limitation of our study was not observing pain scores and opioid requirement without premedication with gabapentinoids (no control group).</p></sec><sec sec-type="conclusion" id="sec1-5"><title>C<sc>ONCLUSION</sc></title><p>A single pre-operative dose of pregabalin (150 mg) or gabapentin (300 mg) are equally efficacious in providing pain relief following laproscopic cholecystectomy as a part of multi-modal regime without any side effects.</p><sec id="sec2-2"><title>Financial support and sponsorship</title><p>Nil.</p></sec><sec id="sec2-3" sec-type="COI-statement"><title>Conflicts of interest</title><p>There are no conflicts of interest.</p></sec></sec></body><back><ack><title>Acknowledgment</title><p>Authors would like to thank the Department of Surgery, Hamdard Institute of Medical Sciences and Research, Jamia Hamdard, New Delhi, India.</p></ack><ref-list><title>R<sc>EFERENCES</sc></title><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buvanendran</surname><given-names>A</given-names></name><name><surname>Kroin</surname><given-names>JS</given-names></name></person-group><article-title>Multimodal analgesia for controlling acute postoperative pain</article-title><source>Curr Opin Anaesthesiol</source><year>2009</year><volume>22</volume><fpage>588</fpage><lpage>93</lpage><pub-id pub-id-type="pmid">19606021</pub-id></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ho</surname><given-names>KY</given-names></name><name><surname>Gan</surname><given-names>TJ</given-names></name><name><surname>Habib</surname><given-names>AS</given-names></name></person-group><article-title>Gabapentin and postoperative pain &#x02013; A systematic review of randomized controlled trials</article-title><source>Pain</source><year>2006</year><volume>126</volume><fpage>91</fpage><lpage>101</lpage><pub-id pub-id-type="pmid">16846695</pub-id></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kong</surname><given-names>VK</given-names></name><name><surname>Irwin</surname><given-names>MG</given-names></name></person-group><article-title>Gabapentin: A multimodal perioperative drug?</article-title><source>Br J Anaesth</source><year>2007</year><volume>99</volume><fpage>775</fpage><lpage>86</lpage><pub-id pub-id-type="pmid">18006529</pub-id></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tiippana</surname><given-names>EM</given-names></name><name><surname>Hamunen</surname><given-names>K</given-names></name><name><surname>Kontinen</surname><given-names>VK</given-names></name><name><surname>Kalso</surname><given-names>E</given-names></name></person-group><article-title>Do surgical patients benefit from perioperative gabapentin/pregabalin? A systematic review of efficacy and safety</article-title><source>Anesth Analg</source><year>2007</year><volume>104</volume><fpage>1545</fpage><lpage>56</lpage><pub-id pub-id-type="pmid">17513656</pub-id></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Ho</surname><given-names>KY</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name></person-group><article-title>Efficacy of pregabalin in acute postoperative pain: A meta-analysis</article-title><source>Br J Anaesth</source><year>2011</year><volume>106</volume><fpage>454</fpage><lpage>62</lpage><pub-id pub-id-type="pmid">21357616</pub-id></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gajraj</surname><given-names>NM</given-names></name></person-group><article-title>Pregabalin: Its pharmacology and use in pain management</article-title><source>Anesth Analg</source><year>2007</year><volume>105</volume><fpage>1805</fpage><lpage>15</lpage><pub-id pub-id-type="pmid">18042886</pub-id></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bryans</surname><given-names>JS</given-names></name><name><surname>Wustrow</surname><given-names>DJ</given-names></name></person-group><article-title>3-substituted GABA analogs with central nervous system activity: A review</article-title><source>Med Res Rev</source><year>1999</year><volume>19</volume><fpage>149</fpage><lpage>77</lpage><pub-id pub-id-type="pmid">10189176</pub-id></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lauria-Horner</surname><given-names>BA</given-names></name><name><surname>Pohl</surname><given-names>RB</given-names></name></person-group><article-title>Pregabalin: A new anxiolytic</article-title><source>Expert Opin Investig Drugs</source><year>2003</year><volume>12</volume><fpage>663</fpage><lpage>72</lpage></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agarwal</surname><given-names>A</given-names></name><name><surname>Gautam</surname><given-names>S</given-names></name><name><surname>Gupta</surname><given-names>D</given-names></name><name><surname>Agarwal</surname><given-names>S</given-names></name><name><surname>Singh</surname><given-names>PK</given-names></name><name><surname>Singh</surname><given-names>U</given-names></name></person-group><article-title>Evaluation of a single preoperative dose of pregabalin for attenuation of postoperative pain after laparoscopic cholecystectomy</article-title><source>Br J Anaesth</source><year>2008</year><volume>101</volume><fpage>700</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">18716003</pub-id></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balaban</surname><given-names>F</given-names></name><name><surname>Yagar</surname><given-names>S</given-names></name><name><surname>&#x000d6;zg&#x000f6;k</surname><given-names>A</given-names></name><name><surname>Ko&#x000e7;</surname><given-names>M</given-names></name><name><surname>G&#x000fc;llapoglu</surname><given-names>H</given-names></name></person-group><article-title>A randomized, placebo-controlled study of pregabalin for postoperative pain intensity after laparoscopic cholecystectomy</article-title><source>J Clin Anesth</source><year>2012</year><volume>24</volume><fpage>175</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">22459341</pub-id></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pandey</surname><given-names>CK</given-names></name><name><surname>Priye</surname><given-names>S</given-names></name><name><surname>Singh</surname><given-names>S</given-names></name><name><surname>Singh</surname><given-names>U</given-names></name><name><surname>Singh</surname><given-names>RB</given-names></name><name><surname>Singh</surname><given-names>PK</given-names></name></person-group><article-title>Preemptive use of gabapentin significantly decreases postoperative pain and rescue analgesic requirements in laparoscopic cholecystectomy</article-title><source>Can J Anaesth</source><year>2004</year><volume>51</volume><fpage>358</fpage><lpage>63</lpage><pub-id pub-id-type="pmid">15064265</pub-id></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rajendran</surname><given-names>I</given-names></name><name><surname>Basavareddy</surname><given-names>A</given-names></name><name><surname>Meher</surname><given-names>BR</given-names></name><name><surname>Srinivasan</surname><given-names>S</given-names></name></person-group><article-title>Prospective, randomised, double blinded controlled trial of gabapentin and pregabalin as pre emptive analgesia in patients undergoing lower abdominal and limb surgery under spinal anaesthesia</article-title><source>Indian J Pain</source><year>2014</year><volume>28</volume><fpage>155</fpage><lpage>9</lpage></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kohli</surname><given-names>M</given-names></name><name><surname>Murali</surname><given-names>T</given-names></name><name><surname>Gupta</surname><given-names>R</given-names></name><name><surname>Khan</surname><given-names>P</given-names></name><name><surname>Bogra</surname><given-names>J</given-names></name></person-group><article-title>Optimization of subarachanoid block by oral pregabalin for hysterectomy</article-title><source>J Anaesthesiol Clin Pharmacol</source><year>2011</year><volume>27</volume><fpage>101</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">21804717</pub-id></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pal</surname><given-names>S</given-names></name><name><surname>Dasgupta</surname><given-names>S</given-names></name><name><surname>Mukhopadhyay</surname><given-names>S</given-names></name><name><surname>Chaudhuri</surname><given-names>A</given-names></name></person-group><article-title>A comparative study between oral pregabalin and gabapentin in prolongation of postoperative pain relief after spinal anesthesia</article-title><source>Indian J Pain</source><year>2016</year><volume>30</volume><fpage>7</fpage><lpage>12</lpage></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mishra</surname><given-names>R</given-names></name><name><surname>Tripathi</surname><given-names>M</given-names></name><name><surname>Chandola</surname><given-names>HC</given-names></name></person-group><article-title>Comparative clinical study of gabapentin and pregabalin for postoperative analgesia in laparoscopic cholecystectomy</article-title><source>Anesth Essays Res</source><year>2016</year><volume>10</volume><fpage>201</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">27212747</pub-id></element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vadivelu</surname><given-names>N</given-names></name><name><surname>Mitra</surname><given-names>S</given-names></name><name><surname>Schermer</surname><given-names>E</given-names></name><name><surname>Kodumudi</surname><given-names>V</given-names></name><name><surname>Kaye</surname><given-names>AD</given-names></name><name><surname>Urman</surname><given-names>RD</given-names></name></person-group><article-title>Preventive analgesia for postoperative pain control: A broader concept</article-title><source>Local Reg Anesth</source><year>2014</year><volume>7</volume><fpage>17</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">24872720</pub-id></element-citation></ref><ref id="ref17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gilron</surname><given-names>I</given-names></name></person-group><article-title>Gabapentin and pregabalin for chronic neuropathic and early postsurgical pain: Current evidence and future directions</article-title><source>Curr Opin Anaesthesiol</source><year>2007</year><volume>20</volume><fpage>456</fpage><lpage>72</lpage><pub-id pub-id-type="pmid">17873599</pub-id></element-citation></ref><ref id="ref18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>PW</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Farcas</surname><given-names>E</given-names></name><name><surname>Haley</surname><given-names>A</given-names></name><name><surname>Wong</surname><given-names>W</given-names></name><name><surname>Bender</surname><given-names>J</given-names></name><etal/></person-group><article-title>Use of low-dose pregabalin in patients undergoing laparoscopic cholecystectomy</article-title><source>Br J Anaesth</source><year>2010</year><volume>105</volume><fpage>155</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">20581215</pub-id></element-citation></ref><ref id="ref19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pandey</surname><given-names>CK</given-names></name><name><surname>Navkar</surname><given-names>DV</given-names></name><name><surname>Giri</surname><given-names>PJ</given-names></name><name><surname>Raza</surname><given-names>M</given-names></name><name><surname>Behari</surname><given-names>S</given-names></name><name><surname>Singh</surname><given-names>RB</given-names></name><etal/></person-group><article-title>Evaluation of the optimal preemptive dose of gabapentin for postoperative pain relief after lumbar diskectomy: A randomized, double-blind, placebo-controlled study</article-title><source>J Neurosurg Anesthesiol</source><year>2005</year><volume>17</volume><fpage>65</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">15840990</pub-id></element-citation></ref><ref id="ref20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Montazeri</surname><given-names>K</given-names></name><name><surname>Kashefi</surname><given-names>P</given-names></name><name><surname>Honarmand</surname><given-names>A</given-names></name></person-group><article-title>Pre-emptive gabapentin significantly reduces postoperative pain and morphine demand following lower extremity orthopaedic surgery</article-title><source>Singapore Med J</source><year>2007</year><volume>48</volume><fpage>748</fpage><lpage>51</lpage><pub-id pub-id-type="pmid">17657384</pub-id></element-citation></ref><ref id="ref21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarakatsianou</surname><given-names>C</given-names></name><name><surname>Theodorou</surname><given-names>E</given-names></name><name><surname>Georgopoulou</surname><given-names>S</given-names></name><name><surname>Stamatiou</surname><given-names>G</given-names></name><name><surname>Tzovaras</surname><given-names>G</given-names></name></person-group><article-title>Effect of pre-emptive pregabalin on pain intensity and postoperative morphine consumption after laparoscopic cholecystectomy</article-title><source>Surg Endosc</source><year>2013</year><volume>27</volume><fpage>2504</fpage><lpage>11</lpage><pub-id pub-id-type="pmid">23344509</pub-id></element-citation></ref><ref id="ref22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jokela</surname><given-names>R</given-names></name><name><surname>Ahonen</surname><given-names>J</given-names></name><name><surname>Tallgren</surname><given-names>M</given-names></name><name><surname>Haanp&#x000e4;&#x000e4;</surname><given-names>M</given-names></name><name><surname>Korttila</surname><given-names>K</given-names></name></person-group><article-title>A randomized controlled trial of perioperative administration of pregabalin for pain after laparoscopic hysterectomy</article-title><source>Pain</source><year>2008</year><volume>134</volume><fpage>106</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">17507163</pub-id></element-citation></ref><ref id="ref23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>SY</given-names></name><name><surname>Jeong</surname><given-names>JJ</given-names></name><name><surname>Chung</surname><given-names>WY</given-names></name><name><surname>Kim</surname><given-names>HJ</given-names></name><name><surname>Nam</surname><given-names>KH</given-names></name><name><surname>Shim</surname><given-names>YH</given-names></name></person-group><article-title>Perioperative administration of pregabalin for pain after robot-assisted endoscopic thyroidectomy: A randomized clinical trial</article-title><source>Surg Endosc</source><year>2010</year><volume>24</volume><fpage>2776</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">20376496</pub-id></element-citation></ref><ref id="ref24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turan</surname><given-names>A</given-names></name><name><surname>Memis</surname><given-names>D</given-names></name><name><surname>Karamanlioglu</surname><given-names>B</given-names></name><name><surname>Yagiz</surname><given-names>R</given-names></name><name><surname>Pamuk&#x000e7;u</surname><given-names>Z</given-names></name><name><surname>Yavuz</surname><given-names>E</given-names></name></person-group><article-title>The analgesic effects of gabapentin in monitored anesthesia care for ear-nose-throat surgery</article-title><source>Anesth Analg</source><year>2004</year><volume>99</volume><fpage>375</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">15271709</pub-id></element-citation></ref><ref id="ref25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghai</surname><given-names>A</given-names></name><name><surname>Gupta</surname><given-names>M</given-names></name><name><surname>Hooda</surname><given-names>S</given-names></name><name><surname>Singla</surname><given-names>D</given-names></name><name><surname>Wadhera</surname><given-names>R</given-names></name></person-group><article-title>A randomized controlled trial to compare pregabalin with gabapentin for postoperative pain in abdominal hysterectomy</article-title><source>Saudi J Anaesth</source><year>2011</year><volume>5</volume><fpage>252</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">21957402</pub-id></element-citation></ref><ref id="ref26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saraswat</surname><given-names>V</given-names></name><name><surname>Arora</surname><given-names>V</given-names></name></person-group><article-title>Preemptive gabapentin vs. pregabalin for acute post-operative pain after surgery under spinal anaesthesia</article-title><source>Indian J Anaesth</source><year>2008</year><volume>52</volume><fpage>829</fpage><lpage>34</lpage></element-citation></ref></ref-list></back></article>